MONTELUKAST

MONTELUKAST was reported 123348 times

These side effects are most commonly reported by patients taking MONTELUKAST:

# Side effect Count
0 DYSPNOEA 8512
1 ASTHMA 8137
2 DRUG INEFFECTIVE 6565
3 FATIGUE 6033
4 HEADACHE 5265
5 COUGH 5169
6 NAUSEA 4646
7 OFF LABEL USE 4406
8 PNEUMONIA 4339
9 PAIN 4020
10 DIARRHOEA 3778
11 ANXIETY 3645
12 WHEEZING 3630
13 DIZZINESS 3243
14 MALAISE 3241
15 PRURITUS 3235
16 RASH 3180
17 VOMITING 3074
18 ARTHRALGIA 2791
19 PYREXIA 2622
20 PRODUCT DOSE OMISSION ISSUE 2614
21 INSOMNIA 2472
22 DEPRESSION 2458
23 URTICARIA 2410
24 CONDITION AGGRAVATED 2360
25 PRODUCT USE IN UNAPPROVED INDICATION 2337
26 FALL 2265
27 ASTHENIA 2222
28 HYPERTENSION 2032
29 HYPERSENSITIVITY 1960
30 PAIN IN EXTREMITY 1947
31 WEIGHT DECREASED 1944
32 NASOPHARYNGITIS 1899
33 COVID-19 1880
34 DEATH 1878
35 CHEST DISCOMFORT 1843
36 DRUG HYPERSENSITIVITY 1819
37 SINUSITIS 1790
38 BACK PAIN 1711
39 WEIGHT INCREASED 1660
40 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1656
41 CONSTIPATION 1602
42 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1562
43 GASTROOESOPHAGEAL REFLUX DISEASE 1559
44 PRODUCTIVE COUGH 1553
45 INJECTION SITE PAIN 1549
46 CHEST PAIN 1533
47 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1533
48 FEELING ABNORMAL 1465
49 ERYTHEMA 1449
50 INFLUENZA 1444
51 BLOOD PRESSURE INCREASED 1425
52 PRODUCT USE ISSUE 1415
53 PERIPHERAL SWELLING 1366
54 DECREASED APPETITE 1324
55 ABDOMINAL PAIN UPPER 1323
56 SLEEP DISORDER 1298
57 UPPER RESPIRATORY TRACT INFECTION 1296
58 BRONCHITIS 1284
59 INFECTION 1281
60 ABDOMINAL PAIN 1266
61 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1258
62 MUSCLE SPASMS 1251
63 ILLNESS 1239
64 NIGHTMARE 1235
65 SOMNOLENCE 1229
66 URINARY TRACT INFECTION 1227
67 NASAL CONGESTION 1218
68 TREMOR 1201
69 GAIT DISTURBANCE 1181
70 AGGRESSION 1175
71 SUICIDAL IDEATION 1174
72 CHRONIC KIDNEY DISEASE 1148
73 OROPHARYNGEAL PAIN 1139
74 OBSTRUCTIVE AIRWAYS DISORDER 1106
75 ACUTE KIDNEY INJURY 1105
76 HYPERHIDROSIS 1065
77 MYALGIA 1064
78 PARAESTHESIA 1051
79 ABDOMINAL DISCOMFORT 1030
80 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1013
81 HEART RATE INCREASED 999
82 HOSPITALISATION 999
83 JOINT SWELLING 994
84 HYPOAESTHESIA 985
85 HYPOTENSION 959
86 DEPRESSED MOOD 939
87 RHINORRHOEA 939
88 MEMORY IMPAIRMENT 907
89 DYSPNOEA EXERTIONAL 905
90 ALOPECIA 899
91 OEDEMA PERIPHERAL 892
92 VISION BLURRED 886
93 LOWER RESPIRATORY TRACT INFECTION 882
94 CONTUSION 875
95 PSORIASIS 875
96 MIGRAINE 863
97 CONFUSIONAL STATE 855
98 OXYGEN SATURATION DECREASED 851
99 RENAL FAILURE 849
100 PALPITATIONS 845
101 INCORRECT DOSE ADMINISTERED 826
102 DRUG INTERACTION 787
103 DRUG INTOLERANCE 786
104 OEDEMA 773
105 ANGER 770
106 INFUSION RELATED REACTION 761
107 FULL BLOOD COUNT ABNORMAL 756
108 ANAEMIA 754
109 RHEUMATOID ARTHRITIS 746
110 ANAPHYLACTIC REACTION 741
111 HALLUCINATION 737
112 INTENTIONAL PRODUCT MISUSE 735
113 DYSPHONIA 731
114 SWELLING 731
115 DRY SKIN 727
116 LUNG DISORDER 723
117 AGITATION 719
118 BURNING SENSATION 717
119 DYSPEPSIA 705
120 CHILLS 702
121 CARDIAC DISORDER 692
122 OVERDOSE 687
123 ABNORMAL BEHAVIOUR 676
124 RASH ERYTHEMATOUS 674
125 IMPAIRED QUALITY OF LIFE 671
126 FLUID RETENTION 669
127 RESPIRATORY TRACT INFECTION 669
128 SLEEP APNOEA SYNDROME 667
129 ATRIAL FIBRILLATION 664
130 HEPATIC ENZYME INCREASED 662
131 ANGIOEDEMA 653
132 DERMATITIS ATOPIC 653
133 DISCOMFORT 653
134 MUSCULAR WEAKNESS 653
135 STRESS 641
136 BALANCE DISORDER 639
137 DEHYDRATION 633
138 HYPOTHYROIDISM 631
139 ECZEMA 627
140 THROMBOCYTOPENIA 619
141 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 615
142 ABDOMINAL DISTENSION 614
143 NO ADVERSE EVENT 612
144 IRRITABILITY 607
145 SPUTUM DISCOLOURED 599
146 VISUAL IMPAIRMENT 596
147 DRY MOUTH 588
148 INTENTIONAL PRODUCT USE ISSUE 580
149 INJECTION SITE ERYTHEMA 574
150 SLEEP TERROR 572
151 SWELLING FACE 571
152 SEASONAL ALLERGY 570
153 PRODUCT QUALITY ISSUE 569
154 ARTHRITIS 568
155 EXPOSURE DURING PREGNANCY 567
156 LOSS OF CONSCIOUSNESS 567
157 HYPOXIA 566
158 NEUROPATHY PERIPHERAL 566
159 PULMONARY EMBOLISM 566
160 EPISTAXIS 565
161 MUSCULOSKELETAL STIFFNESS 562
162 THROMBOSIS 550
163 EYE PAIN 540
164 DYSPHAGIA 536
165 SEIZURE 536
166 TACHYCARDIA 534
167 RESPIRATORY FAILURE 531
168 FOOD ALLERGY 528
169 MIDDLE INSOMNIA 527
170 TREATMENT FAILURE 527
171 THERAPEUTIC RESPONSE DECREASED 521
172 CRYING 514
173 GENERAL PHYSICAL HEALTH DETERIORATION 513
174 RHINITIS ALLERGIC 512
175 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 511
176 SEPSIS 511
177 FLUSHING 510
178 DRY EYE 508
179 IMMUNODEFICIENCY 505
180 DISTURBANCE IN ATTENTION 504
181 HAEMOPTYSIS 499
182 GASTROINTESTINAL DISORDER 496
183 THERAPY INTERRUPTED 494
184 MOOD ALTERED 491
185 CEREBROVASCULAR ACCIDENT 489
186 HOT FLUSH 487
187 SKIN EXFOLIATION 487
188 EMOTIONAL DISTRESS 486
189 THROAT IRRITATION 486
190 BLOOD GLUCOSE INCREASED 485
191 BLOOD TEST ABNORMAL 485
192 INFLUENZA LIKE ILLNESS 479
193 ADVERSE DRUG REACTION 475
194 SYNCOPE 474
195 CATARACT 471
196 BLOOD PRESSURE DECREASED 466
197 FIBROMYALGIA 463
198 WHITE BLOOD CELL COUNT DECREASED 463
199 OSTEOPOROSIS 461
200 RENAL DISORDER 458
201 PRODUCT SUBSTITUTION ISSUE 456
202 CELLULITIS 455
203 MOOD SWINGS 454
204 BLOOD COUNT ABNORMAL 451
205 MOBILITY DECREASED 451
206 PRODUCT DOSE OMISSION 448
207 AMNESIA 446
208 HERPES ZOSTER 446
209 BLOOD PRESSURE SYSTOLIC INCREASED 442
210 DRUG DOSE OMISSION 441
211 EYE IRRITATION 440
212 PANIC ATTACK 432
213 INJECTION SITE SWELLING 430
214 INJECTION SITE PRURITUS 427
215 DISEASE RECURRENCE 423
216 PRESCRIBED OVERDOSE 423
217 PLATELET COUNT DECREASED 420
218 RESPIRATORY TRACT CONGESTION 419
219 VERTIGO 419
220 CARDIAC FAILURE CONGESTIVE 415
221 FEELING HOT 408
222 INJECTION SITE BRUISING 407
223 RASH PRURITIC 404
224 HAEMOGLOBIN DECREASED 403
225 MEDICATION ERROR 396
226 CARPAL TUNNEL SYNDROME 394
227 EOSINOPHILIA 394
228 DIABETES MELLITUS 392
229 NECK PAIN 391
230 EYE PRURITUS 390
231 PULMONARY FIBROSIS 388
232 SNEEZING 380
233 SURGERY 380
234 LETHARGY 377
235 PRODUCT DOSE OMISSION IN ERROR 374
236 NEUTROPENIA 372
237 OSTEOARTHRITIS 371
238 VIRAL INFECTION 366
239 MATERNAL EXPOSURE DURING PREGNANCY 360
240 PLEURAL EFFUSION 359
241 RESPIRATORY DISORDER 359
242 ASTHMATIC CRISIS 358
243 FORCED EXPIRATORY VOLUME DECREASED 357
244 MYOCARDIAL INFARCTION 357
245 ACCIDENTAL EXPOSURE TO PRODUCT 355
246 LIP SWELLING 354
247 BONE PAIN 351
248 EAR INFECTION 350
249 OCULAR HYPERAEMIA 348
250 POOR QUALITY SLEEP 347
251 UNEVALUABLE EVENT 346
252 MENTAL DISORDER 345
253 BURSITIS 341
254 CARDIAC FAILURE 341
255 PSYCHOMOTOR HYPERACTIVITY 341
256 SINUS DISORDER 341
257 CONTRAINDICATED PRODUCT ADMINISTERED 340
258 NERVOUSNESS 339
259 SECRETION DISCHARGE 339
260 ABNORMAL DREAMS 336
261 TYPE 2 DIABETES MELLITUS 332
262 DYSGEUSIA 330
263 BLISTER 329
264 RENAL IMPAIRMENT 329
265 ILL-DEFINED DISORDER 327
266 SPEECH DISORDER 324
267 SWOLLEN TONGUE 323
268 SKIN DISCOLOURATION 321
269 BLOOD CREATININE INCREASED 317
270 FLATULENCE 317
271 COELIAC DISEASE 316
272 HAEMORRHAGE 316
273 EYE SWELLING 314
274 FUNGAL INFECTION 314
275 RESPIRATORY SYMPTOM 311
276 THERAPY CESSATION 310
277 BRONCHIECTASIS 309
278 TEMPERATURE REGULATION DISORDER 309
279 NEPHROLITHIASIS 305
280 THERAPY NON-RESPONDER 304
281 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 303
282 BRONCHOSPASM 297
283 INJECTION SITE REACTION 295
284 NASAL POLYPS 295
285 THERAPEUTIC RESPONSE SHORTENED 293
286 ADVERSE EVENT 291
287 INTENTIONAL DOSE OMISSION 290
288 GASTROINTESTINAL HAEMORRHAGE 288
289 FOETAL DEATH 287
290 INFLAMMATION 287
291 MULTIPLE ALLERGIES 286
292 CARDIAC ARREST 285
293 LACRIMATION INCREASED 284
294 RESTLESSNESS 284
295 SENSITISATION 284
296 THROAT TIGHTNESS 284
297 DISEASE PROGRESSION 281
298 RHINITIS 278
299 END STAGE RENAL DISEASE 274
300 DEVICE ISSUE 273
301 POLYCYSTIC OVARIES 273
302 BLOOD IMMUNOGLOBULIN E INCREASED 271
303 RENAL INJURY 270
304 VASCULITIS 269
305 PULMONARY MASS 266
306 CHOLELITHIASIS 265
307 PARANOIA 262
308 WITHDRAWAL SYNDROME 261
309 RASH MACULAR 260
310 SUICIDE ATTEMPT 260
311 HYPERGLYCAEMIA 259
312 DEEP VEIN THROMBOSIS 258
313 PULMONARY OEDEMA 257
314 STOMATITIS 256
315 PSORIATIC ARTHROPATHY 255
316 EOSINOPHIL COUNT INCREASED 254
317 TOXICITY TO VARIOUS AGENTS 254
318 HYPOACUSIS 252
319 UNDERDOSE 252
320 BRAIN FOG 250
321 BLOOD POTASSIUM DECREASED 249
322 TIC 249
323 TINNITUS 246
324 WHITE BLOOD CELL COUNT INCREASED 246
325 HYPONATRAEMIA 245
326 ARTHROPATHY 244
327 EAR PAIN 244
328 NEURALGIA 244
329 COMPLETED SUICIDE 243
330 RALES 243
331 MUSCULOSKELETAL PAIN 242
332 CYSTITIS 241
333 FEAR 241
334 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 240
335 SKIN DISORDER 239
336 INFUSION SITE PAIN 238
337 SINUS CONGESTION 238
338 EMOTIONAL DISORDER 237
339 EXPOSURE VIA SKIN CONTACT 237
340 CHOKING 234
341 FEBRILE NEUTROPENIA 232
342 POLLAKIURIA 232
343 THERAPEUTIC RESPONSE UNEXPECTED 232
344 UPPER-AIRWAY COUGH SYNDROME 232
345 CANDIDA INFECTION 231
346 LIMB INJURY 231
347 OBSESSIVE-COMPULSIVE DISORDER 231
348 STAPHYLOCOCCAL INFECTION 231
349 ORAL HERPES 229
350 NIGHT SWEATS 227
351 FEELING COLD 226
352 OBESITY 226
353 EYE DISORDER 225
354 GAIT INABILITY 225
355 BLOOD CHOLESTEROL INCREASED 224
356 ACNE 222
357 DRUG DEPENDENCE 222
358 DIVERTICULITIS 221
359 QUALITY OF LIFE DECREASED 221
360 THINKING ABNORMAL 221
361 DISORIENTATION 220
362 BREATH SOUNDS ABNORMAL 216
363 EJECTION FRACTION 216
364 RETCHING 216
365 ACUTE RESPIRATORY FAILURE 214
366 TRANSIENT ISCHAEMIC ATTACK 214
367 DEVICE MALFUNCTION 212
368 INFUSION SITE ERYTHEMA 212
369 INTENTIONAL SELF-INJURY 212
370 PHARYNGEAL SWELLING 212
371 RESPIRATORY DISTRESS 209
372 HEART RATE DECREASED 208
373 HYPERSOMNIA 208
374 HYPOKALAEMIA 207
375 NASAL OEDEMA 207
376 PRODUCT PRESCRIBING ERROR 207
377 JOINT INJURY 206
378 PANCREATITIS 206
379 PSYCHOTIC DISORDER 205
380 CROHN^S DISEASE 204
381 HAEMATOCHEZIA 202
382 TREATMENT NONCOMPLIANCE 202
383 PLASMA CELL MYELOMA 201
384 GOUT 200
385 BACTERIAL INFECTION 199
386 INSURANCE ISSUE 199
387 DYSURIA 198
388 EMPHYSEMA 195
389 LIMB DISCOMFORT 195
390 HEAD INJURY 193
391 SKIN LESION 193
392 THERAPEUTIC PRODUCT EFFECT DECREASED 193
393 INJECTION SITE HAEMORRHAGE 191
394 COGNITIVE DISORDER 190
395 RESPIRATORY RATE INCREASED 190
396 LEUKOPENIA 189
397 MOVEMENT DISORDER 188
398 BLOOD PRESSURE FLUCTUATION 187
399 DRUG DOSE OMISSION BY DEVICE 187
400 HAEMATOMA 187
401 LIVER FUNCTION TEST INCREASED 187
402 SKIN BURNING SENSATION 187
403 AGEUSIA 186
404 PULMONARY CONGESTION 186
405 ROAD TRAFFIC ACCIDENT 186
406 DYSSTASIA 185
407 SCRATCH 185
408 SOMNAMBULISM 185
409 CHRONIC SINUSITIS 184
410 PAIN IN JAW 184
411 PULMONARY ALVEOLAR HAEMORRHAGE 184
412 GASTROENTERITIS VIRAL 183
413 HALLUCINATION, AUDITORY 183
414 ALANINE AMINOTRANSFERASE INCREASED 182
415 ARRHYTHMIA 182
416 DYSKINESIA 182
417 RESPIRATION ABNORMAL 182
418 NEUROLOGICAL SYMPTOM 181
419 PROCEDURAL PAIN 181
420 APHASIA 180
421 CONJUNCTIVITIS 180
422 HIATUS HERNIA 180
423 LYMPHADENOPATHY 180
424 RESPIRATORY SYNCYTIAL VIRUS INFECTION 180
425 IMPAIRED GASTRIC EMPTYING 179
426 GLAUCOMA 177
427 HALLUCINATION, VISUAL 177
428 INJURY 176
429 CYSTIC FIBROSIS 174
430 LUNG INFECTION 174
431 PULMONARY VASCULITIS 174
432 URINARY RETENTION 174
433 DYSARTHRIA 173
434 INTERSTITIAL LUNG DISEASE 173
435 ANOSMIA 172
436 HYPOGLYCAEMIA 172
437 NODULE 171
438 BODY TEMPERATURE DECREASED 170
439 INJECTION SITE RASH 170
440 INTERVERTEBRAL DISC PROTRUSION 170
441 GASTRITIS 168
442 PHOTOPHOBIA 167
443 APHONIA 166
444 URINARY INCONTINENCE 166
445 MULTIPLE SCLEROSIS RELAPSE 165
446 SKIN FISSURES 165
447 ANHEDONIA 164
448 NEOPLASM MALIGNANT 164
449 RESTLESS LEGS SYNDROME 164
450 ASPARTATE AMINOTRANSFERASE INCREASED 163
451 BLOOD GLUCOSE DECREASED 163
452 OCULAR DISCOMFORT 163
453 CHRONIC SPONTANEOUS URTICARIA 161
454 DEVICE DELIVERY SYSTEM ISSUE 161
455 BLOOD PRESSURE ABNORMAL 160
456 HEART RATE IRREGULAR 160
457 SKIN PLAQUE 160
458 MUSCLE TWITCHING 159
459 NEURITIS 159
460 RIB FRACTURE 159
461 PRESYNCOPE 158
462 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 158
463 GASTRIC DISORDER 157
464 SYSTEMIC LUPUS ERYTHEMATOSUS 157
465 INTESTINAL OBSTRUCTION 156
466 NEPHROGENIC ANAEMIA 156
467 PERSONALITY CHANGE 156
468 RECTAL HAEMORRHAGE 156
469 SKIN IRRITATION 156
470 ANAPHYLACTIC SHOCK 155
471 ARTERIOSCLEROSIS CORONARY ARTERY 155
472 ORAL PAIN 155
473 PULMONARY FUNCTION TEST ABNORMAL 155
474 ASPIRATION 153
475 CHROMATURIA 153
476 DUST ALLERGY 153
477 EATING DISORDER 153
478 INFUSION SITE SWELLING 153
479 LOCALISED INFECTION 153
480 THIRST 153
481 FOOT FRACTURE 152
482 DERMATITIS 151
483 INJECTION SITE URTICARIA 151
484 TRANSAMINASES INCREASED 151
485 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 150
486 HEPATIC STEATOSIS 150
487 NEUTROPHIL COUNT DECREASED 150
488 ARTERIOSCLEROSIS 149
489 BLOOD CALCIUM INCREASED 149
490 C-REACTIVE PROTEIN INCREASED 149
491 MITE ALLERGY 149
492 PNEUMONIA ASPIRATION 149
493 SENSITIVITY TO WEATHER CHANGE 149
494 DIPLOPIA 148
495 ANGINA PECTORIS 147
496 ANKLE FRACTURE 147
497 PRODUCT STORAGE ERROR 147
498 BRADYCARDIA 146
499 IMPAIRED WORK ABILITY 146
500 KIDNEY INFECTION 146
501 PNEUMONITIS 146
502 WOUND 146
503 BREAST CANCER 145
504 CONJUNCTIVITIS ALLERGIC 145
505 DECREASED ACTIVITY 145
506 PULMONARY HYPERTENSION 145
507 INITIAL INSOMNIA 144
508 LIVER DISORDER 144
509 PRODUCT ADMINISTRATION INTERRUPTED 144
510 HIP FRACTURE 143
511 KNEE ARTHROPLASTY 143
512 PRODUCT AVAILABILITY ISSUE 143
513 RED BLOOD CELL COUNT DECREASED 143
514 PERICARDIAL EFFUSION 142
515 TOTAL LUNG CAPACITY ABNORMAL 142
516 DRUG ABUSE 141
517 DRUG-INDUCED LIVER INJURY 141
518 PULMONARY FUNCTION TEST DECREASED 141
519 SKIN HAEMORRHAGE 141
520 INTERVERTEBRAL DISC DEGENERATION 140
521 OBSTRUCTION 140
522 TASTE DISORDER 140
523 LABORATORY TEST ABNORMAL 139
524 SOCIAL AVOIDANT BEHAVIOUR 139
525 UPPER LIMB FRACTURE 139
526 MENTAL STATUS CHANGES 138
527 MUSCULOSKELETAL CHEST PAIN 138
528 PHARYNGITIS 138
529 LACTIC ACIDOSIS 137
530 MAST CELL ACTIVATION SYNDROME 137
531 RESPIRATORY DEPRESSION 137
532 SEPTIC SHOCK 137
533 SPIROMETRY ABNORMAL 137
534 LUNG OPACITY 136
535 MYCOTIC ALLERGY 136
536 DERMATITIS CONTACT 135
537 ELECTROCARDIOGRAM QT PROLONGED 135
538 BONE DENSITY DECREASED 134
539 HEAD DISCOMFORT 133
540 PULMONARY THROMBOSIS 133
541 HYPOPHAGIA 132
542 LUNG NEOPLASM MALIGNANT 131
543 PARAESTHESIA ORAL 131
544 SARS-COV-2 TEST POSITIVE 131
545 FAECES DISCOLOURED 130
546 INJECTION SITE MASS 130
547 OSTEOPENIA 130
548 FEEDING DISORDER 129
549 IRRITABLE BOWEL SYNDROME 129
550 OBSTRUCTIVE SLEEP APNOEA SYNDROME 129
551 DEAFNESS 128
552 HAEMATURIA 128
553 HYPERLIPIDAEMIA 128
554 PNEUMOTHORAX 128
555 EAR DISCOMFORT 127
556 MOUTH ULCERATION 127
557 SPINAL FRACTURE 127
558 BODY TEMPERATURE INCREASED 125
559 HEREDITARY ANGIOEDEMA 125
560 OROPHARYNGEAL DISCOMFORT 125
561 SENSORY DISTURBANCE 125
562 DIASTOLIC DYSFUNCTION 124
563 EXTRA DOSE ADMINISTERED 124
564 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 124
565 TOOTHACHE 124
566 MUSCULOSKELETAL DISCOMFORT 123
567 NEEDLE ISSUE 123
568 PHOTOSENSITIVITY REACTION 123
569 COVID-19 PNEUMONIA 122
570 FULL BLOOD COUNT DECREASED 122
571 PALLOR 122
572 PNEUMONIA BACTERIAL 122
573 LARYNGITIS 121
574 SELF-INJURIOUS IDEATION 121
575 SPINAL OPERATION 121
576 ADRENAL INSUFFICIENCY 120
577 HERNIA 120
578 JOINT STIFFNESS 120
579 SCIATICA 120
580 TEMPERATURE INTOLERANCE 120
581 IMPAIRED HEALING 118
582 BACK DISORDER 117
583 BLOOD IRON DECREASED 117
584 TUBULOINTERSTITIAL NEPHRITIS 117
585 THERAPY PARTIAL RESPONDER 116
586 DEMENTIA 115
587 FOETAL EXPOSURE DURING PREGNANCY 115
588 FRUSTRATION TOLERANCE DECREASED 115
589 MULTIPLE SCLEROSIS 115
590 TOTAL LUNG CAPACITY DECREASED 115
591 WEIGHT FLUCTUATION 115
592 DRUG EFFECT DECREASED 114
593 INCREASED APPETITE 114
594 INTENTIONAL OVERDOSE 114
595 MICTURITION URGENCY 114
596 TOOTH ABSCESS 114
597 VITAMIN D DEFICIENCY 114
598 GASTROENTERITIS 113
599 IMMUNE SYSTEM DISORDER 113
600 SCREAMING 113
601 SPUTUM INCREASED 113
602 BENIGN PROSTATIC HYPERPLASIA 112
603 HYSTERECTOMY 112
604 COLITIS 111
605 LIGAMENT SPRAIN 111
606 ORAL CANDIDIASIS 111
607 POST PROCEDURAL COMPLICATION 111
608 DECREASED IMMUNE RESPONSIVENESS 110
609 NORMOCHROMIC NORMOCYTIC ANAEMIA 110
610 PANCYTOPENIA 110
611 REBOUND ACID HYPERSECRETION 110
612 COMA 109
613 TOOTH DISORDER 109
614 ATTENTION DEFICIT HYPERACTIVITY DISORDER 108
615 CARDIAC MURMUR 108
616 DYSPNOEA AT REST 108
617 EYE INFECTION 108
618 GLUCOSE TOLERANCE IMPAIRED 108
619 NEPHROPATHY 108
620 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 107
621 BLOOD URINE PRESENT 107
622 BODY HEIGHT DECREASED 107
623 DIZZINESS POSTURAL 107
624 ERUCTATION 107
625 ROTATOR CUFF SYNDROME 107
626 EYE DISCHARGE 106
627 FACE OEDEMA 106
628 INFUSION SITE HAEMORRHAGE 106
629 MULTIPLE FRACTURES 106
630 PRURITUS GENERALISED 106
631 CLOSTRIDIUM DIFFICILE INFECTION 105
632 SKIN INFECTION 105
633 BEHAVIOUR DISORDER 104
634 BLINDNESS 104
635 BRONCHIAL SECRETION RETENTION 104
636 HYPERKALAEMIA 104
637 MAJOR DEPRESSION 104
638 PAIN OF SKIN 104
639 PHARYNGITIS STREPTOCOCCAL 104
640 SKIN LACERATION 104
641 TENDONITIS 104
642 EJECTION FRACTION ABNORMAL 103
643 GLOSSODYNIA 103
644 HAEMATOCRIT DECREASED 103
645 FLANK PAIN 102
646 HAEMATEMESIS 102
647 LIVER FUNCTION TEST ABNORMAL 102
648 PANCREATITIS ACUTE 102
649 PRODUCT USE COMPLAINT 102
650 SINUS TACHYCARDIA 102
651 SKIN ULCER 102
652 ASPHYXIA 101
653 BLOOD SODIUM DECREASED 101
654 DEPRESSED LEVEL OF CONSCIOUSNESS 101
655 FACIAL PAIN 101
656 PRODUCT ADMINISTRATION ERROR 101
657 PRODUCT TASTE ABNORMAL 101
658 TENDERNESS 101
659 TOOTH INFECTION 101
660 AFFECT LABILITY 100
661 CONCUSSION 100
662 DECREASED INTEREST 100
663 DEPRESSION SUICIDAL 100
664 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 100
665 IRON DEFICIENCY ANAEMIA 100
666 WRIST FRACTURE 100
667 APATHY 99
668 COLITIS ULCERATIVE 99
669 DRY THROAT 99
670 INFUSION SITE PRURITUS 99
671 INTERNATIONAL NORMALISED RATIO INCREASED 99
672 NOCTURIA 99
673 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 98
674 DELIRIUM 98
675 PHARYNGEAL OEDEMA 98
676 PSYCHIATRIC SYMPTOM 98
677 PERIPHERAL COLDNESS 97
678 DRUG EFFECT LESS THAN EXPECTED 96
679 MENTAL IMPAIRMENT 96
680 PRODUCT PRESCRIBING ISSUE 96
681 RASH PAPULAR 96
682 ATELECTASIS 95
683 EXERCISE TOLERANCE DECREASED 95
684 FEELING JITTERY 95
685 MANIA 95
686 MUSCLE TIGHTNESS 95
687 LEUKOCYTOSIS 94
688 ORAL DISCOMFORT 94
689 POOR VENOUS ACCESS 94
690 SCAR 94
691 CHOKING SENSATION 93
692 COLD SWEAT 93
693 DERMATITIS ALLERGIC 93
694 ENURESIS 93
695 MALIGNANT NEOPLASM PROGRESSION 93
696 PLEURITIC PAIN 93
697 PRE-EXISTING CONDITION IMPROVED 93
698 PURPURA 93
699 THROAT CLEARING 93
700 BIPOLAR DISORDER 92
701 SKIN SWELLING 92
702 DRUG EFFECT INCOMPLETE 91
703 LOWER LIMB FRACTURE 91
704 NEPHRECTOMY 91
705 ORTHOSTATIC HYPOTENSION 91
706 OSTEONECROSIS 91
707 BRONCHIAL WALL THICKENING 90
708 CEREBRAL HAEMORRHAGE 90
709 MOUTH HAEMORRHAGE 90
710 NERVE COMPRESSION 89
711 PAPULE 89
712 APPETITE DISORDER 88
713 DEVICE LEAKAGE 88
714 PLATELET COUNT INCREASED 88
715 RASH GENERALISED 88
716 SWELLING OF EYELID 88
717 AUTOIMMUNE DISORDER 87
718 GALLBLADDER DISORDER 87
719 GLYCOSYLATED HAEMOGLOBIN INCREASED 87
720 HAEMORRHOIDS 87
721 HYPERCHOLESTEROLAEMIA 87
722 JOINT DISLOCATION 87
723 CHEST X-RAY ABNORMAL 86
724 EXPIRED PRODUCT ADMINISTERED 86
725 HIP ARTHROPLASTY 86
726 INCORRECT PRODUCT ADMINISTRATION DURATION 86
727 SKIN CANCER 86
728 SUPRAVENTRICULAR TACHYCARDIA 86
729 CARDIO-RESPIRATORY ARREST 85
730 CORONARY ARTERY DISEASE 85
731 INFUSION SITE DISCHARGE 85
732 MUSCULOSKELETAL DISORDER 85
733 ACUTE MYOCARDIAL INFARCTION 84
734 AFFECTIVE DISORDER 84
735 BLOOD POTASSIUM INCREASED 84
736 CARDIOMYOPATHY 84
737 NERVOUS SYSTEM DISORDER 84
738 PETECHIAE 84
739 SYMPTOM RECURRENCE 84
740 THYROID DISORDER 84
741 PERIORBITAL SWELLING 83
742 PRODUCT DISTRIBUTION ISSUE 83
743 SUICIDAL BEHAVIOUR 83
744 EJECTION FRACTION DECREASED 82
745 DYSPHEMIA 81
746 HEPATITIS 81
747 INCREASED TENDENCY TO BRUISE 81
748 BACK INJURY 80
749 CYANOSIS 80
750 DIVERTICULUM 80
751 HYPERPARATHYROIDISM SECONDARY 80
752 MACULAR DEGENERATION 80
753 NEGATIVE THOUGHTS 80
754 RHABDOMYOLYSIS 80
755 TRICUSPID VALVE INCOMPETENCE 80
756 DEPRESSIVE SYMPTOM 79
757 FEMUR FRACTURE 78
758 FREQUENT BOWEL MOVEMENTS 78
759 HUNGER 78
760 POST-TRAUMATIC STRESS DISORDER 78
761 SCAB 78
762 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 77
763 EPILEPSY 77
764 MOUTH SWELLING 77
765 PRODUCT PREPARATION ERROR 77
766 SEDATION 77
767 VITAMIN D DECREASED 77
768 ABORTION SPONTANEOUS 76
769 CARDIOMEGALY 76
770 COORDINATION ABNORMAL 76
771 CYTOKINE RELEASE SYNDROME 76
772 ECONOMIC PROBLEM 76
773 HYPERVENTILATION 76
774 HYPOAESTHESIA ORAL 76
775 INTERNAL HAEMORRHAGE 76
776 METABOLIC ACIDOSIS 76
777 SNORING 76
778 ULCER 76
779 VAGINAL HAEMORRHAGE 75
780 ARTHROPOD BITE 74
781 DISABILITY 74
782 DRUG WITHDRAWAL SYNDROME 74
783 ENCEPHALOPATHY 74
784 HEPATIC FUNCTION ABNORMAL 74
785 HYPOGAMMAGLOBULINAEMIA 74
786 NASAL DISCHARGE DISCOLOURATION 74
787 PRODUCT PHYSICAL ISSUE 74
788 ALLERGIC GRANULOMATOUS ANGIITIS 73
789 DEVICE DISLOCATION 73
790 HEPATIC FAILURE 73
791 MALIGNANT MELANOMA 73
792 MUSCLE STRAIN 73
793 NEUROPSYCHIATRIC SYMPTOMS 73
794 NEUROPSYCHOLOGICAL SYMPTOMS 73
795 POLYP 73
796 RHONCHI 73
797 BRONCHIAL HYPERREACTIVITY 72
798 CHOLECYSTECTOMY 72
799 DEVICE BREAKAGE 72
800 PARANASAL SINUS DISCOMFORT 72
801 SHOCK 72
802 TEARFULNESS 72
803 UPPER GASTROINTESTINAL HAEMORRHAGE 72
804 ALLERGY TO ANIMAL 71
805 CHRONIC GRAFT VERSUS HOST DISEASE 71
806 CONCOMITANT DISEASE AGGRAVATED 71
807 EOSINOPHILIC PNEUMONIA 71
808 EYE HAEMORRHAGE 71
809 HAIR TEXTURE ABNORMAL 71
810 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 71
811 LUNG INFILTRATION 71
812 PSEUDOMONAS INFECTION 71
813 ACCIDENT 70
814 BLOOD BILIRUBIN INCREASED 70
815 BLOOD GLUCOSE ABNORMAL 70
816 GASTRIC ULCER 70
817 HAIR COLOUR CHANGES 70
818 HEPATIC CIRRHOSIS 70
819 HYPOCALCAEMIA 70
820 PRODUCT COMPLAINT 70
821 SKIN ABRASION 70
822 BRONCHIAL OBSTRUCTION 69
823 DEVICE FAILURE 69
824 INFECTION SUSCEPTIBILITY INCREASED 69
825 RESPIRATORY ARREST 69
826 VITAL CAPACITY DECREASED 69
827 ANAL INCONTINENCE 68
828 GRIP STRENGTH DECREASED 68
829 HOSPICE CARE 68
830 INFUSION SITE BRUISING 68
831 NASAL DISCOMFORT 68
832 PULMONARY PAIN 68
833 SINUS HEADACHE 68
834 WOUND INFECTION 68
835 BLADDER DISORDER 67
836 DELUSION 67
837 DRUG ERUPTION 67
838 OBSESSIVE-COMPULSIVE SYMPTOM 67
839 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 67
840 TENDON RUPTURE 67
841 ASCITES 66
842 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 66
843 DEVICE USE ERROR 66
844 FEELING DRUNK 66
845 INCONTINENCE 66
846 JAUNDICE 66
847 PAROSMIA 66
848 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 66
849 VISUAL ACUITY REDUCED 66
850 AORTIC VALVE STENOSIS 65
851 BLOOD ALKALINE PHOSPHATASE INCREASED 65
852 BOWEL MOVEMENT IRREGULARITY 65
853 CAPILLARITIS 65
854 CYST 65
855 HEPATOTOXICITY 65
856 HUMAN RHINOVIRUS TEST POSITIVE 65
857 IMMUNOSUPPRESSION 65
858 INCREASED BRONCHIAL SECRETION 65
859 SALIVARY HYPERSECRETION 65
860 BLOOD CREATINE PHOSPHOKINASE INCREASED 64
861 BONE DISORDER 64
862 HAND FRACTURE 64
863 INFUSION SITE EXTRAVASATION 64
864 INHIBITORY DRUG INTERACTION 64
865 INJECTION SITE IRRITATION 64
866 NASAL DRYNESS 64
867 PRODUCT ODOUR ABNORMAL 64
868 PROSTATE CANCER 64
869 SEROTONIN SYNDROME 64
870 SINUSITIS FUNGAL 64
871 TOTAL LUNG CAPACITY INCREASED 64
872 BLOOD PRESSURE DIASTOLIC DECREASED 63
873 CONVULSION 63
874 EYE INFLAMMATION 63
875 MULTIPLE ORGAN DYSFUNCTION SYNDROME 63
876 MYDRIASIS 63
877 PARKINSON^S DISEASE 63
878 PRODUCT DISPENSING ERROR 63
879 PULMONARY ARTERIAL HYPERTENSION 63
880 SARCOIDOSIS 63
881 SENSITIVE SKIN 63
882 ABNORMAL LOSS OF WEIGHT 62
883 ABNORMAL WEIGHT GAIN 62
884 ADVERSE REACTION 62
885 ATRIAL FLUTTER 62
886 BLOOD MAGNESIUM DECREASED 62
887 BODY TINEA 62
888 DEVICE USE ISSUE 62
889 DISSOCIATION 62
890 HYPOKINESIA 62
891 TACHYPNOEA 62
892 UNRESPONSIVE TO STIMULI 62
893 CUSHINGOID 61
894 GENERALISED OEDEMA 61
895 HYPOMAGNESAEMIA 61
896 LUNG HYPERINFLATION 61
897 MYOCARDITIS 61
898 ORAL MUCOSAL BLISTERING 61
899 PARANASAL SINUS HYPERSECRETION 61
900 ABDOMINAL HERNIA 60
901 CHOLESTASIS 60
902 FOOT DEFORMITY 60
903 TONGUE BITING 60
904 DEVICE DIFFICULT TO USE 59
905 DEVICE RELATED INFECTION 59
906 EOSINOPHIL COUNT ABNORMAL 59
907 FEELING OF DESPAIR 59
908 INJECTION SITE DISCOMFORT 59
909 INTRUSIVE THOUGHTS 59
910 PNEUMONIA VIRAL 59
911 RIGHT ATRIAL HYPERTROPHY 59
912 RIGHT VENTRICULAR HYPERTROPHY 59
913 TOOTH EXTRACTION 59
914 BLOOD CALCIUM DECREASED 58
915 BLOOD IMMUNOGLOBULIN G DECREASED 58
916 DRUG ADMINISTRATION ERROR 58
917 DRUG RESISTANCE 58
918 FORMICATION 58
919 LEFT VENTRICULAR HYPERTROPHY 58
920 PSYCHOLOGICAL TRAUMA 58
921 SINUS OPERATION 58
922 SINUS PAIN 58
923 SKIN REACTION 58
924 ABDOMINAL PAIN LOWER 57
925 BRONCHIAL DISORDER 57
926 ERECTILE DYSFUNCTION 57
927 HORDEOLUM 57
928 INCORRECT DOSE ADMINISTERED BY DEVICE 57
929 JUVENILE IDIOPATHIC ARTHRITIS 57
930 MYASTHENIA GRAVIS 57
931 PLEURISY 57
932 PNEUMONIA HAEMOPHILUS 57
933 POST PROCEDURAL INFECTION 57
934 PRESCRIBED UNDERDOSE 57
935 SPINAL OSTEOARTHRITIS 57
936 ALTERED STATE OF CONSCIOUSNESS 56
937 BLOOD UREA INCREASED 56
938 COMPLICATION ASSOCIATED WITH DEVICE 56
939 GASTROINTESTINAL INFECTION 56
940 GINGIVAL PAIN 56
941 INJECTION SITE DISCOLOURATION 56
942 PARALYSIS 56
943 SPINAL DISORDER 56
944 SPINAL STENOSIS 56
945 ACTIVITIES OF DAILY LIVING IMPAIRED 55
946 DEFIANT BEHAVIOUR 55
947 EPIDURAL LIPOMATOSIS 55
948 EXOSTOSIS 55
949 INABILITY TO AFFORD MEDICATION 55
950 KNEE OPERATION 55
951 MADAROSIS 55
952 NEOPLASM 55
953 ROSACEA 55
954 TOOTH FRACTURE 55
955 ABSCESS 54
956 ASPIRIN-EXACERBATED RESPIRATORY DISEASE 54
957 BLINDNESS UNILATERAL 54
958 BRUXISM 54
959 FACIAL PARALYSIS 54
960 FEMALE GENITAL TRACT FISTULA 54
961 FORCED VITAL CAPACITY DECREASED 54
962 GESTATIONAL DIABETES 54
963 HYPERTHYROIDISM 54
964 INJECTION SITE WARMTH 54
965 MUSCLE DISORDER 54
966 NASAL DISORDER 54
967 NASAL OBSTRUCTION 54
968 OESOPHAGITIS 54
969 REVERSIBLE AIRWAYS OBSTRUCTION 54
970 STEM CELL TRANSPLANT 54
971 BLOOD PRESSURE DIASTOLIC ABNORMAL 53
972 CARDIAC FLUTTER 53
973 DEVICE DEFECTIVE 53
974 DIABETES MELLITUS INADEQUATE CONTROL 53
975 EAR PRURITUS 53
976 GASTROINTESTINAL PAIN 53
977 GENERALISED TONIC-CLONIC SEIZURE 53
978 GINGIVAL BLEEDING 53
979 HEMIPARESIS 53
980 OBSESSIVE THOUGHTS 53
981 RENAL TUBULAR NECROSIS 53
982 RHINOVIRUS INFECTION 53
983 SKIN ATROPHY 53
984 SQUAMOUS CELL CARCINOMA OF SKIN 53
985 THERAPY CHANGE 53
986 ADJUSTMENT DISORDER 52
987 BASAL CELL CARCINOMA 52
988 DIABETIC KETOACIDOSIS 52
989 EMBOLISM VENOUS 52
990 GLOSSITIS 52
991 JOINT RANGE OF MOTION DECREASED 52
992 PROSTATOMEGALY 52
993 REBOUND EFFECT 52
994 RESPIRATORY ACIDOSIS 52
995 SENSATION OF FOREIGN BODY 52
996 STEVENS-JOHNSON SYNDROME 52
997 ASPERGILLUS INFECTION 51
998 COAGULOPATHY 51
999 FRACTURE 51